Natalia Ramírez Pedraza

Natalia Ramírez Pedraza

Auto-generated profile, based on publicly available information

Natalia Ramírez Pedraza

From the Department of Radiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, Mexico City, Mexico 14080 (N.R.P., A.H.P.S., J.A.G.M., M.C.I., S.A.R., M.R.A.R.); Department of Radiology, Medical College of Wisconsin, Milwaukee, Wis (K.T.); Department of Radiology, Mayo Clinic, Jacksonville, Fla (A.W.B.); and Department of Radiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico (M.A.C.M.).

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in RadioGraphics
Verified
Journal Article
Closed access
NPNatalia Ramírez Pedraza
Natalia Ramírez Pedraza
ASAarón Horeb Pérez Segovia
Aarón Horeb Pérez Segovia
JMJuan Alberto Garay Mora
Juan Alberto Garay Mora
KTKurt Techawatanaset
Kurt Techawatanaset
ABAndrew W. Bowman
Andrew W. Bowman
MRMaría Rebeca Arizaga Ramírez
María Rebeca Arizaga Ramírez
Perianal fistulas can be associated with significant morbidity, and knowledge of how they arise, how to image them, and their classification is paramount to ensure appropriate patient treatment.

13 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PVPablo Esteban Vanegas-Cedillo
Pablo Esteban Vanegas-Cedillo
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
NRNatalia Ramírez-Pedraza
Natalia Ramírez-Pedraza
BEBethsabel Rodríguez Encinas
Bethsabel Rodríguez Encinas
CCCarolina Isabel Pérez Carrión
Carolina Isabel Pérez Carrión
RMRoopa Mehta
Roopa Mehta
INTRODUCTION Coronavirus disease (COVID-19) is a global pandemic. Vitamin D (25-OHD) deficiency has been associated with susceptibility to infectious disease. In this study, the association between COVID-19 outcomes and 25-OHD levels in patients attending a COVID-19 reference center in Mexico City are examined. METHODS Consecutive patients with confirmed COVID-19 were evaluated. All patients underwent clinical evaluation (including outcomes), laboratory measurements (including 25-OHD) and a thoracic computerized tomography (including the measurement of epicardial fat thickness). Low vitamin D was defined as levels <20ng/mL (<50nmol/L) and severely low (or deficient) 25-OHD as a level ≤12ng/mL (<30nmol/L) RESULTS Of the 551 patients included, low 25-OHD levels were present in 45.6% and severely low levels in 10.9%. Severely low 25-OHD levels were associated with mortality (HR 2.11, 95%CI 1.24-3.58, p=0.006) but not with critical COVID-19 (OR 0.97, 95%CI 0.94-0.99, p=0.042), adjusted for age, sex, body-mass index and epicardial fat. Using model-based causal mediation analyses the increased risk of COVID-19 mortality conferred by 25-OHD levels was partly mediated by its effect on D-dimer and cardiac ultrasensitive troponins. Notably, increased risk of COVID-19 mortality conferred by low vitamin D levels was independent of BMI and epicardial fat. CONCLUSION Vitamin D deficiency (≤12ng/mL or <30nmol/L), is independently associated with COVID-19 mortality after adjustment for visceral fat (epicardial fat thickness). Low 25-OHD may contribute to a pro-inflammatory and pro-thrombotic state, increasing the risk for adverse COVID-19 outcomes.

24 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RMRoopa Mehta
Roopa Mehta
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
LMLeonardo Mancillas-Adame
Leonardo Mancillas-Adame
Marcela Rodríguez-FloresMarcela Rodríguez-Flores
Marcela Rodríguez-Flores
NPNatalia Ramírez Pedraza
Natalia Ramírez Pedraza
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
BACKGROUND Obesity, in particular, visceral adipose tissue has been linked to adverse COVID-19 outcomes. The amount of epicardial adipose tissue (EAT) may have relevant implications given its proximity to the heart and lungs. Here, we explored the role of EAT in increasing the risk for COVID-19 adverse outcomes. METHODS We included 748 patients with COVID-19 attending a reference centre in Mexico City. EAT thickness, sub-thoracic and pericardial fat were measured using thoracic CT scans. We explored the association of each thoracic adipose tissue compartment with critical COVID-19 and mortality according to the presence or absence of obesity. Mediation analyses evaluated the role of EAT in facilitating the effect of age, body mass index and cardiac troponin levels with adverse COVID-19 outcomes. RESULTS EAT thickness was associated with increased risk of COVID-19 mortality (HR 1.18, 95%CI 1.01-1.39) independent of age, gender, comorbid conditions and BMI. Increased EAT was associated with lower SpO2 and PaFi index and higher levels of cardiac troponins, D-dimer, C-reactive protein, and 4C severity score, independent of obesity. EAT mediated 13.1% (95%CI 3.67-28.0%) and 5.1% (95%CI 0.19-14.0%) of the effect of age and 19.4% (95%CI 4.67-63.0%) and 12.8% (95%CI 0.03-46.0%) of the effect of BMI on requirement for intubation and mortality, respectively. EAT also mediated the effect of increased cardiac troponins on myocardial infarction during COVID-19. CONCLUSION EAT is an independent risk factor for severe COVID-19 and mortality independent of obesity. EAT partly mediates the effect of age and BMI and increased cardiac troponins on adverse COVID-19 outcomes.